Genelux GNLX
NASDAQ GNLX
$2.06 -0.01 (-0.59%)
As of: Oct 22, 2026 · 12:27 PM EDT

Genelux (GNLX) Long-Term Debt Repayments (2022 - 2023)

Updated

Genelux (GNLX) posted Long-Term Debt Repayments of $685,000 for FY2023, up 426.9% from $130,000 in FY2022.

Analysis

Genelux (GNLX) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends

  • Business Quant data shows GNLX's Long-Term Debt Repayments at $130,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn 1.00 Mn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn 2.00 Bn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn 2.46 Bn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn -
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Genelux 90.51 Mn 28.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 25,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 460,000.00
Mar 31, 2022 130,000.00
API Access

Genelux Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=GNLX&period=max&api_key=YOUR_API_KEY